Haematology

Uzm. Dr. Tahir Alper Cinli

Doctor and researcher Başakşehir Çam ve Sakura Şehir Hastanesi İstanbul
COVID-19Multiple Myeloma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Multiple Myeloma 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • InstitutionBaşakşehir Çam ve Sakura Şehir Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 3 publications · Model version —From source
  • Publications28 publicationsORCID, OpenAlex, Europe PMCFrom source
  • ORCID0000-0003-2164-9776ORCIDFrom source
  • Last synchronised5 November 2026 10:36https://camsakurasehir.saglik.gov.tr/TR-1290328/gorev-yapan-hekimlerimiz.html#tahir-alper-cinlisaglik.gov.tr

Scientific work

Publications on COVID-19

28 publications

  1. Is Baseline PET/CT-Derived Metabolic Tumor Burden Associated with Treatment Response and Survival in Hodgkin Lymphoma?

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15176686 PMID 42739691 Open-access full textSource: ORCID

  2. Comparative Prognostic Performance of Nutritional Indices in Acute Myeloid Leukemia

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166179 PMID 42652583 Open-access full textSource: ORCID

  3. Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15124703 PMID 42355871 Open-access full textSource: ORCID

  4. Integrated Prognostic Modelling with the CALLY Index and Interim PET/CT in Hodgkin Lymphoma

    Cancers, 2026

    DOI 10.3390/cancers18193205 PMID 42882899 Open-access full textSource: OpenAlex

  5. Beyond conventional genetics: impact of next-generation sequencing integration in acute myeloid leukemia

    Experimental Biomedical Research, 2026

    DOI 10.30714/j-ebr.2026.284 Open-access full textSource: ORCID

  6. Clinical and Laboratory Associations of JAK2 V617F Variant Allele Frequency in Patients With JAK2 V617F‐Positive Erythrocytosis: A Single‐Centre Retrospective Analysis

    International Journal of Laboratory Hematology, 2026

    DOI 10.1111/ijlh.70242 PMID 42689474 Open-access full textSource: ORCID

  7. Synergistic Contribution of HFE H63D Mutation to Secondary Polycythemia Pathogenesis at Moderate–High Altitude: A Retrospective Cohort Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16132087 PMID 42449868 Open-access full textSource: ORCID

  8. Acid Sphingomyelinase Deficiency in an Adult with Unexplained Splenomegaly Despite Negative <i>SMPD1</i> Sequencing: A Case Report

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2026

    DOI 10.4274/tjh.galenos.2026.20599 PMID 42786969 Open-access full textSource: Europe PMC

  9. The Effect of Hepatitis B and Alcohol Coexistence on the Development of Hepatocellular Carcinoma in Cirrhotic Patients

    Istanbul Medical Journal, 2026

    DOI 10.4274/imj.galenos.2026.02073 Open-access full textSource: OpenAlex

  10. Ibrutinib-Associated Kaposi Sarcoma and Reversible Renal Manifestation in Chronic Lymphocytic Leukemia

    Cam and Sakura Medical Journal, 2026

    DOI 10.4274/csmedj.galenos.2026.2026-7-4 Open-access full textSource: OpenAlex

View all 28 publications